WeMed Medical Has Been Invited To Take Part in BIOHK 2025 in Hong Kong.
Recently, the BIOHK 2025 Hong Kong International Biotech Forum and Exhibition, hosted by the Hong Kong Biotechnology Association, successfully concluded at the Hong Kong Convention and Exhibition Centre. Recognized as one of Asia's most influential international biotechnology events, this year's forum attracted leading experts, scholars, industry executives, investment institutions, and innovative enterprises from more than 20 countries and regions. Participants came together to explore emerging trends and opportunities in the biomedical industry.
With the support of the Economic-Technological Development Area, WeMed Medical joined several regional innovators to form the "Yizhuang Biomedical Delegation". Invited to make a collective appearance at the exhibition, the delegation took part in a series of high-level business exchanges under the themes of "attracting projects, promoting transformation, and expanding markets". These efforts highlighted to the global community the innovative strength and open outlook of Beijing Yizhuang as a leading hub for China's pharmaceutical and healthcare sector.
During the forum's keynote session, Yang He, CEO of WeMed Medical, introduced the company's self-developed integrated "Eye-Hand-Brain" interventional robotic system. Incorporating advanced technologies such as artificial intelligence, precision control, and image navigation, the system represents an intelligent upgrade for interventional procedures-delivering enhanced visibility, tactile feedback, and cognitive support. It greatly improves surgical precision and efficiency while easing physicians' workload and reducing patient risks.
Yang He offered an in-depth analysis covering core technical parameters, clinical application scenarios, and market value potential, underscoring WeMed Medical's expertise and innovative strength in the high-end medical equipment sector. Recognized for its strong technological foundation, clear business model, and vast market prospects, WeMed Medical distinguished itself among numerous exhibitors and received the "Best Exhibit of the Day" award, drawing significant attention and praise from investment institutions and industry experts alike.
WeMed Medical's impressive presence at BIOHK 2025 not only showcased the company's technological strength and growth potential but also underscored the strong appeal and leadership of the Beijing Economic-Technological Development Area as the capital's leading hub for high-precision industries.
Looking ahead, WeMed Medical will continue to uphold its mission of "uarding Lives with Technology" while deepening its expertise in interventional diagnosis and treatment. The company remains committed to translating innovative achievements into clinical practice, delivering more precise, safer, and more efficient medical solutions for patients worldwide, and strengthening the voice of China's biomedical industry on the global stage.
